ZA941160B - Oxytocin antagonists for the inhibition of pre-term labor - Google Patents

Oxytocin antagonists for the inhibition of pre-term labor

Info

Publication number
ZA941160B
ZA941160B ZA941160A ZA941160A ZA941160B ZA 941160 B ZA941160 B ZA 941160B ZA 941160 A ZA941160 A ZA 941160A ZA 941160 A ZA941160 A ZA 941160A ZA 941160 B ZA941160 B ZA 941160B
Authority
ZA
South Africa
Prior art keywords
oxytocin
inhibition
compound
term labor
oxytocin antagonists
Prior art date
Application number
ZA941160A
Other languages
English (en)
Inventor
George Flouret
Laird Wilson
Original Assignee
Univ Northwestern
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Northwestern filed Critical Univ Northwestern
Publication of ZA941160B publication Critical patent/ZA941160B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/16Oxytocins; Vasopressins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06Antiabortive agents; Labour repressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/26Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Paints Or Removers (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA941160A 1993-04-26 1994-02-21 Oxytocin antagonists for the inhibition of pre-term labor ZA941160B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/052,887 US5373089A (en) 1988-09-02 1993-04-26 Oxytocin antagonist

Publications (1)

Publication Number Publication Date
ZA941160B true ZA941160B (en) 1994-09-20

Family

ID=21980563

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA941160A ZA941160B (en) 1993-04-26 1994-02-21 Oxytocin antagonists for the inhibition of pre-term labor

Country Status (24)

Country Link
US (1) US5373089A (xx)
EP (1) EP0695309B1 (xx)
JP (1) JPH10507995A (xx)
KR (1) KR100291304B1 (xx)
CN (1) CN1041634C (xx)
AT (1) ATE182898T1 (xx)
AU (1) AU681399B2 (xx)
BR (2) BR9405914A (xx)
CA (1) CA2155872C (xx)
CZ (1) CZ285388B6 (xx)
DE (1) DE69419910T2 (xx)
DK (1) DK0695309T3 (xx)
ES (1) ES2134351T3 (xx)
FI (1) FI105921B (xx)
GR (1) GR3031432T3 (xx)
HU (1) HU217972B (xx)
IL (1) IL108685A (xx)
NO (1) NO954260L (xx)
NZ (1) NZ266049A (xx)
PL (1) PL177055B1 (xx)
RU (1) RU2120944C1 (xx)
SK (1) SK130295A3 (xx)
WO (1) WO1994025485A1 (xx)
ZA (1) ZA941160B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE501678C2 (sv) * 1993-07-13 1995-04-10 Ferring Bv Peptid med oxytocinantagonistaktivitet samt farmaceutisk komposition innehållande nämnda peptid
ATE305781T1 (de) 1996-02-23 2005-10-15 Lilly Co Eli Non-peptidische vasopressin via antagonisten
EP0983769A4 (en) * 1997-04-14 2002-05-02 Mitsubishi Tokyo Pharm Inc PERMUCOSE FORMULATION
EP0896001A1 (en) * 1997-08-08 1999-02-10 Daicel Chemical Industries, Ltd. Method for preparing oxytocin antagoniste derivatives, intermediates for the preparation of oxytocin antagonist derivatives and method for preparing the intermediates
JP2003335797A (ja) * 2000-06-28 2003-11-28 Daicel Chem Ind Ltd ペプチド化合物及びそれを有効成分とする医薬組成物
EP1555029A1 (en) * 2004-01-19 2005-07-20 Ferring B.V. Use of substances having oxytocin antagonistic properties for the preparation of a medicament for treating hypertension

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4597901A (en) * 1984-12-14 1986-07-01 Smithkline Beckman Corporation β-indolylalanyl or β-indolylglycinyl vasopressin antagonists
US4711877A (en) * 1985-09-18 1987-12-08 Smithkline Beckman Corporation 6-pen-vasopressin compounds
AU4211089A (en) * 1988-09-02 1990-04-02 Northwestern University Oxytocin antagonist
US5070187A (en) * 1989-11-03 1991-12-03 Trustees Of Boston University Pharmacologically effective antagonists of arginine-vasopressin

Also Published As

Publication number Publication date
PL311475A1 (en) 1996-02-19
NZ266049A (en) 1996-09-25
RU2120944C1 (ru) 1998-10-27
ATE182898T1 (de) 1999-08-15
AU681399B2 (en) 1997-08-28
FI953646A0 (fi) 1995-07-31
WO1994025485A1 (en) 1994-11-10
CA2155872A1 (en) 1994-11-10
AU6663094A (en) 1994-11-21
CZ277895A3 (en) 1996-01-17
FI953646A (fi) 1995-10-11
DE69419910D1 (de) 1999-09-09
KR100291304B1 (ko) 2001-06-01
HU9502366D0 (en) 1996-05-28
CA2155872C (en) 2001-02-06
EP0695309B1 (en) 1999-08-04
ES2134351T3 (es) 1999-10-01
CN1121709A (zh) 1996-05-01
PL177055B1 (pl) 1999-09-30
IL108685A0 (en) 1994-05-30
CZ285388B6 (cs) 1999-07-14
DE69419910T2 (de) 1999-12-09
DK0695309T3 (da) 2000-02-07
IL108685A (en) 1998-01-04
KR960701897A (ko) 1996-03-28
GR3031432T3 (en) 2000-01-31
NO954260D0 (no) 1995-10-25
BR9405914A (pt) 1996-04-02
FI105921B (fi) 2000-10-31
EP0695309A1 (en) 1996-02-07
BR1101113A (pt) 2000-06-06
JPH10507995A (ja) 1998-08-04
US5373089A (en) 1994-12-13
HUT74945A (en) 1997-03-28
SK130295A3 (en) 1996-02-07
CN1041634C (zh) 1999-01-13
NO954260L (no) 1995-10-25
HU217972B (hu) 2000-05-28

Similar Documents

Publication Publication Date Title
HU9400495D0 (en) Peptides having growth hormone releasing activity
IL124459A0 (en) Antagonists of gonadotropin releasing hormone
MX9804850A (es) Antagonistas de hormona liberadora de gonadotropina.
AU7941887A (en) Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists
MY103212A (en) Zinc-protamine-alpha interferon complex
BG108806A (en) IIb/IIIa CELL ADHESION INHIIBITORS, METHOD FOR THE PRODUCTION, PHARMACEUTCIAL COMPOSITION AND ADMINISTRATION THEREOF
CA2022444A1 (en) Lhrh analogs
GB2212499B (en) "novel 6-position cyclosporin analogs as non-immunosuppressive antagonists of cyclosporin binding to cyclophilin
ES8308698A1 (es) Procedimiento para preparar una composicion penetrable por la piel a base de agentes terapeuticos sistematicamente activos
GB2054603B (en) Nonapeptide and decapeptide derivatives of luteinizing hormone releasing hormone
AU4982085A (en) Nona and decapeptide analogs of LHRH useful as LHRH antagonists
ZA941160B (en) Oxytocin antagonists for the inhibition of pre-term labor
MX9700245A (es) Nuevo compuesto quimico, su preparacion y su empleo como medicamento.
IL78017A (en) Sustained release tablets of theophylline
EP0328090A3 (en) Lhrh analogs
HRP920585B1 (en) Method of design and synthesis of lutheinizing hormone releasing hormone antagonists, products and use thereof
GB1298587A (en) Methods of contraception and contraceptive compositions
AU2802700A (en) Utilization of dienogest in high doses
ZA834240B (en) Nonapeptide and decapeptide analogs of lhrh useful as lhrh antagonists
BG99062A (en) POLYMORPH "A" OF N-t-BUTYL-ANDROST-3,5-DIENE-17 -CARBOXAMIDE-3-CARBOXYLIC ACID
MX9804819A (es) Antagonistas de hormona liberadora de gonadotropina.
MX9703018A (es) Antagonistas de progesterona competentes para regular la fertilidad femenina segun se requiera.